Took the chart all the way back out to 2015 to find some relevant levels and did a quick fib retracement. Aside from the 236 level being a key point of resistance, in 2015, the area around $5.20 presented an interesting area of high traffic. SESN managed to break through this briefly but as you'll see, it was fleeting after putting in the top that I used as the upper anchor. Heading into the end of the week, this area could be important to watch.
"SENS stock is another decent gainer of the day, pushing up by around 8% in afternoon trading. For some context, Senseonics is a producer of medical products that monitor metrics for those with diabetes. Its product line includes several CGM (continuous glucose monitoring) systems such as the Eversense and Eversense XL...These devices utilize a sensor inserted under the skin to track a patient’s glucose levels. It can then send this data to a smartphone which puts it ahead of the existing technology by quite a ways. At the beginning of this week, Senseonics announced its second-quarter 2021 financial results. In the report, the company posted revenue of around $3.3 million and managed to raise more than $50 million in proceeds through an at-the-market offering...In the U.S. and around the world, diabetes is a condition that affects millions. Because of this, Senseonics could have a sizable market opportunity moving forward. For these reasons, SENS stock could be worth keeping an eye on."
Quote Source & Read more: Best Penny Stocks to Buy Now? 4 to Watch to Avoid Stock Market Crash
"SENS stock is another decent gainer of the day, pushing up by around 8% in afternoon trading. For some context, Senseonics is a producer of medical products that monitor metrics for those with diabetes. Its product line includes several CGM (continuous glucose monitoring) systems such as the Eversense and Eversense XL...These devices utilize a sensor inserted under the skin to track a patient’s glucose levels. It can then send this data to a smartphone which puts it ahead of the existing technology by quite a ways. At the beginning of this week, Senseonics announced its second-quarter 2021 financial results. In the report, the company posted revenue of around $3.3 million and managed to raise more than $50 million in proceeds through an at-the-market offering...In the U.S. and around the world, diabetes is a condition that affects millions. Because of this, Senseonics could have a sizable market opportunity moving forward. For these reasons, SENS stock could be worth keeping an eye on."
Quote Source & Read more: Best Penny Stocks to Buy Now? 4 to Watch to Avoid Stock Market Crash